Inhibition of p53 transcriptional activity by human cytomegalovirus UL44

Microbiology and Immunology

Volumn 56, Issue 5, 2012, Pages 324-331

  Kwon, Yejin ^a   Kim, Mi Na ^b   Young Choi, Eun ^a   Heon Kim, Jung ^a   Hwang, Eung Soo ^a   Cha, Chang Yong ^a,c  

^a Seoul National University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Korea Hydro & Nuclear Power Co   (South Korea)

Author keywords

Human cytomegalovirus; P21; P53; UL44

Indexed keywords

MESSENGER RNA; PROTEIN P21; PROTEIN P53; UL44 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; NONHUMAN; PLASMID; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION;

CELL LINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA-BINDING PROTEINS; DOWN-REGULATION; HUMANS; PROTEIN BINDING; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53; VIRAL PROTEINS;

HUMAN HERPESVIRUS 5;

EID: 84860371773     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2012.00446.x     Document Type: Article

References (40)

1. Fiala M., Payne J.E., Berne T.V., Moore T.C., Henle W., Montgomerie J.Z., Chatterjee S.N., Guze L.B. (1975) Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. J Infect Dis 132: 421-33.
2. Jacobson M.A., Mills J. (1988) Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment. Ann Intern Med 108: 585-94.
3. Light J.A., Burke D.S. (1979) Association of cytomegalovirus (CMV) infections with increased recipient mortality following transplantation. Transplant Proc 11: 79-82.
4. DeMarchi J.M. (1983) Correlation between stimulation of host cell DNA synthesis by human cytomegalovirus and lack of expression of a subset of early virus genes. Virology 129: 274-86.
5. Casavant N.C., Luo M.H., Rosenke K., Winegardner T., Zurawska A., Fortunato E.A. (2006) Potential role for p53 in the permissive life cycle of human cytomegalovirus. J Virol 80: 8390-401.
6. Speir E., Modali R., Huang E.S., Leon M.B., Shawl F., Finkel T., Epstein S.E. (1994) Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265: 391-4.
7. Finlay C.A., Hinds P.W., Levine A.J. (1989) The p53 proto-oncogene can act as a suppressor of transformation. Cell 57: 1083-93.
8. Hollstein M., Sidransky D., Vogelstein B., Harris C.C. (1991) p53 mutations in human cancers. Science 253: 49-53.
9. Levine A.J., Momand J., Finlay C.A. (1991) The p53 tumour suppressor gene. Nature 351: 453-6.
10. Martinez J., Georgoff I., Levine A.J. (1991) Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev 5: 151-9.
11. Baker S.J., Markowitz S., Fearon E.R., Willson J.K., Vogelstein B. (1990) Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912-5.
12. Isaacs W.B., Carter B.S., Ewing C.M. (1991) Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res 51: 4716-20.
13. Mercer W.E., Shields M.T., Amin M., Sauve G.J., Appella E., Romano J.W., Ullrich S.J. (1990) Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci U S A 87: 6166-70.
14. Bonin L.R., McDougall J.K. (1997) Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function. J Virol 71: 5861-70.
15. Tsai H.L., Kou G.H., Chen S.C., Wu C.W., Lin Y.S. (1996) Human cytomegalovirus immediate-early protein IE2 tethers a transcriptional repression domain to p53. J Biol Chem 271: 3534-40.
16. Cha C.Y., Hwang E.S. (1988) Production and characterization of monoclonal antibodies reactive with human cytomegalovirus. J Kor Soc Microbiol 23: 495-504.
17. Hwang E.S., Kim J., Jong H.S., Park J.W., Park C.G., Cha C.Y. (2000) Characteristics of DNA-binding activity of human cytomegalovirus ppUL44. Microbiol Immunol 44: 827-32.
18. Gorman C.M., Moffat L.F., Howard B.H. (1982) Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2: 1044-51.
19. Livak K.J., Schmittgen T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-8.
20. DeMarchi J.M., Schmidt C.A., Kaplan A.S. (1980) Patterns of transcription of human cytomegalovirus in permissively infected cells. J Virol 35: 277-86.
21. McDonough S.H., Staprans S.I., Spector D.H. (1985) Analysis of the major transcripts encoded by the long repeat of human cytomegalovirus strain AD169. J Virol 53: 711-8.
22. Wathen M.W., Stinski M.F. (1982) Temporal patterns of human cytomegalovirus transcription: mapping the viral RNAs synthesized at immediate early, early, and late times after infection. J Virol 41: 462-77.
23. Wathen M.W., Thomsen D.R., Stinski M.F. (1981) Temporal regulation of human cytomegalovirus transcription at immediate early and early times after infection. J Virol 38: 446-59.
24. Jault F.M., Jault J.M., Ruchti F., Fortunato E.A., Clark C., Corbeil J., Richman D.D., Spector D.H. (1995) Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J Virol 69: 6697-704.
25. Muganda P., Mendoza O., Hernandez J., Qian Q. (1994) Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts. J Virol 68: 8028-34.
26. Fortunato E.A., Spector D.H. (1998) p53 and RPA are sequestered in viral replication centers in the nuclei of cells infected with human cytomegalovirus. J Virol 72: 2033-9.
27. Varnum S.M., Streblow D.N., Monroe M.E., Smith P., Auberry K.J., Pasa-Tolic L., Wang D., Camp D.G., 2nd, Rodland K., Wiley S., Britt W., Shenk T., Smith R.D., Nelson J.A. (2004) Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol 78: 10, 960-6.
28. Boccuni M.C., Campanini F., Battista M.C., Bergamini G., Dal Monte P., Ripalti A., Landini M.P. (1998) Human cytomegalovirus product UL44 downregulates the transactivation of HIV-1 long terminal repeat. AIDS 12: 365-72.
29. Wing B.A., Johnson R.A., Huang E.S. (1998) Identification of positive and negative regulatory regions involved in regulating expression of the human cytomegalovirus UL94 late promoter: role of IE2-86 and cellular p53 in mediating negative regulatory function. J Virol 72: 1814-25.
30. Castillo J.P., Yurochko A.D., Kowalik T.F. (2000) Role of human cytomegalovirus immediate-early proteins in cell growth control. J Virol 74: 8028-37.
31. Muganda P., Carrasco R., Qian Q. (1998) The human cytomegalovirus IE2 86 kDa protein elevates p53 levels and transactivates the p53 promoter in human fibroblasts. Cell Mol Biol (Noisy-le-grand) 44: 321-31.
32. Hagemeier C., Walker S., Caswell R., Kouzarides T., Sinclair J. (1992) The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID. J Virol 66: 4452-6.
33. Caswell R., Hagemeier C., Chiou C.J., Hayward G., Kouzarides T., Sinclair J. (1993) The human cytomegalovirus 86K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulation. J Gen Virol 74: 2691-8.
34. Lukac D.M., Harel N.Y., Tanese N., Alwine J.C. (1997) TAF-like functions of human cytomegalovirus immediate-early proteins. J Virol 71: 7227-39.
35. Lukac D.M., Manuppello J.R., Alwine J.C. (1994) Transcriptional activation by the human cytomegalovirus immediate-early proteins: requirements for simple promoter structures and interactions with multiple components of the transcription complex. J Virol 68: 5184-93.
36. Lang D., Gebert S., Arlt H., Stamminger T. (1995) Functional interaction between the human cytomegalovirus 86-kilodalton IE2 protein and the cellular transcription factor CREB. J Virol 69: 6030-7.
37. Yoo Y.D., Chiou C.J., Choi K.S., Yi Y., Michelson S., Kim S., Hayward G.S., Kim S.J. (1996) The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor beta1 gene through an Egr-1 binding site. J Virol 70: 7062-70.
38. Weiland K.L., Oien N.L., Homa F., Wathen M.W. (1994) Functional analysis of human cytomegalovirus polymerase accessory protein. Virus Res 34: 191-206.
39. Ertl P.F., Thomas M.S., Powell K.L. (1991) High level expression of DNA polymerases from herpesviruses. J Gen Virol 72: 1729-34.
40. Ripalti A., Boccuni M.C., Campanini F., Landini M.P. (1995) Cytomegalovirus-mediated induction of antisense mRNA expression to UL44 inhibits virus replication in an astrocytoma cell line: identification of an essential gene. J Virol 69: 2047-57.